Skip to content

Real world study of perioperative optimization intervention strategy for severe proliferative diabetic retinopathy (PDR)

Real world study of perioperative optimization intervention strategy for severe proliferative diabetic retinopathy (PDR)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018238
Enrollment
Unknown
Registered
2018-09-06
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PDR

Interventions

Group 2:general anesthesia combine with preoperative anti-VEGF
Group 3:general anesthesia combine with intraoperative anti-VEGF
Group 4:local and targert-controlled anesthesia
Group 5:local and targert-controlled anesthesia combined with preoperative anti-VEGF
Group 6:local and targert-controlled anesthesia combined with intraoperative anti-VEGF

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged =18 years old; 2) type 1 or type 2 diabetes; 3) tractional vascular detachment caused by retinal fibrovascular proliferation; 4) vitreous hemorrhage, B-ultrasound suggests tractional retinal detachment.

Exclusion criteria

Exclusion criteria: 1) Complete or partial completion of panretinal photocoagulation; 2) History of previous injections of anti-VEGF drugs; 3) combined with rhegmatogenous retinal detachment; 4) iris neovascularization, anterior chamber neovascularization and neovascular glaucoma;

Design outcomes

Primary

MeasureTime frame
Intraoperative bleeding score;

Secondary

MeasureTime frame
time of Intraoperative electrocoagulation;Intraoperative iatrogenic hole;Surgical difficulty score;Early postoperative bleeding;Late postoperative bleeding;Postoperative macular edema;

Contacts

Public ContactYong Wei

The Eye Hospital of Wenzhou Medical University

weiyongdoctor@163.com+86 15057551266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026